T. Rowe Price Associates’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-39,916
| Closed | -$301K | – | 2884 |
|
|
2023
Q1 | $301K | Buy |
39,916
+3,953
| +11% | +$29.8K | ﹤0.01% | 2339 |
|
|
2022
Q4 | $364K | Buy |
35,963
+2,249
| +7% | +$22.8K | ﹤0.01% | 2295 |
|
|
2022
Q3 | $334K | Buy |
33,714
+13,955
| +71% | +$138K | ﹤0.01% | 2327 |
|
|
2022
Q2 | $210K | Buy |
+19,759
| New | +$210K | ﹤0.01% | 2578 |
|